Profitability Ratios
| Ratio |
Value |
| GP Margin |
33.7% |
| EBIT Margin |
12.2% |
| EBITDA Margin |
15.6% |
| Operating Margin |
13.1% |
| Pretax Margin |
9.0% |
| Cont. Ops Margin |
6.6% |
| Net Margin |
6.6% |
| Bottom Line Margin |
6.6% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
2.96 |
| Quick Ratio |
1.27 |
| Solvency Ratio |
0.136 |
| Cash Ratio |
0.19 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
0.12 |
| Forward PEG |
0.12 |
| Price/Book |
3.31 |
| Price/Sales |
0.84 |
| Price/FCF |
129.22 |
| Price/Op Cash Flow |
18.49 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.5254 |
| Debt/Equity |
2.0462 |
| Debt/Capital |
0.6717 |
| Long-Term Debt/Capital |
0.6474 |
| Financial Leverage |
3.89 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
2.67 |
| Operating Cash Flow Ratio |
0.218 |
| Operating Cash Flow/Sales |
4.5% |
| Free Cash Flow/Operating Cash Flow |
14.3% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
2.74 |
| Interest Coverage |
4.1685 |
| Short-Term Operating Cash Flow Coverage |
2.76 |
| Operating Cash Flow Coverage |
0.09 |
| Capital Expenditure Coverage |
1.17 |
| Dividend + Capital Expenditure Coverage |
0.88 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
19.5176% |
| Dividend Yield |
1.5267% |
| Dividend Yield % |
1.5267% |
| Dividend Per Share |
0.4794 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
37.39 |
| EPS |
2.456 |
| Debt/Share |
20.6003 |
| Cash/Share |
2.02 |
| Book Value/Share |
9.49 |
| Tangible BV/Share |
7.28 |
| Equity/Share |
9.49 |
| Operating Cash Flow/Share |
1.698 |
| Capital Expenditure/Share |
1.455 |
| FCF/Share |
0.243 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.726 |
| Earnings Before Tax/EBIT |
0.692 |
| Price/Fair Value |
3.31 |
| Debt/Market Cap |
0.5748 |
| Effective Tax Rate |
27.4% |
| Enterprise Value Multiple |
8.47 |
PAHC - Phibro Animal Health Corporation